The ARMADA study [54] evaluated anti-inflammatory effects of heparin and enoxaparin in Non-ST-Elevated Myocardial Infarction (Non-STEMI) and reported that inflammatory markers (CRP and von Willebrand factor) are affected more by LMWH compared to UFH. This evidence concerns the gene VWF and ST Elevation Myocardial Infarction.